The World in a Grain of Sand: Royalty Pharma

KdT Ventures Partners, Mack Healy & Cain McClary take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Royalty Pharma.

Om Podcasten

The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the life science realm.